glp-1 deaths medications found to reduce deaths, amputations and hospitalisations in PAD and type 2 diabetes patients How Ozempic Affects Your Body:

Description

(You can now subscribe to our Economic Times WhatsApp channel) (Catch all the Business News, Breaking News and Latest News Updates on The Economic Times.) Subscribe to The Economic Times Prime and read the ET ePaper online

"Going right off like that, it's easier said than done," she said

It's a tailored solution backed by cutting-edge research

A thorough medication history, a high index of suspicion for delayed gastric motility, and an understanding of the broader pharmacologic effects of these agents are essential tools for the emergency clinician

Although this class of drugs, called glucagon-like peptide-1 or GLP-1, have been around for more than 17 years, with the first one, Byetta, approved in 2005, it is only recently that the class has made a big name for itself with the introduction of the popular once-weekly diabetic drug, Ozempic , and the equally popular obesity drug, Wegovy (the same drug as Ozempic but with a different dose)